Hemolytic uremic syndrome (HUS) is defined by the triad of mechanical intravascular hemolytic anemia with schistocytosis, thrombocytopenia and acute renal failure. Pulmonary involvement in HUS is known to be rare. We present the case of a 25-year-old male with diffuse alveolar hemorrhage and myocarditis followed by atypical hemolytic uremic syndrome. In this case, successful treatments included steroid pulse therapy for the fatal alveolar hemorrhage and plasma exchange for the hemolytic uremic syndrome.
Diffuse alveolar hemorrhage (DAH) is a life threatening dis-
order with high mortality. [1] The treatment of alveolar hemorrhage varies according to the etiologies. The alveolar hemorrhage in hemolytic uremic syndrome (HUS) has been rarely reported as complication. [2] [3] [4] [5] We report a case of atypical HUS which manifested with alveolar hemorrhage, respiratory failure and myocarditis even before thrombocytopenia and hemolytic anemia developed. We will discuss the causes and treatment of atypical alveolar hemorrhage in this case review.
CASE REPORT
A 25-year-old man was transferred to the emergency department with a 4-day history of fever, dyspnea and hemoptysis, despite having received high-dose corticosteroid therapy in a local tertiary hospital. The patient was a nonsmoker, and did not have any history of drug use, recent travel, tuberculosis exposure, or a significant past medical history.
On physical examination, his temperature was 38.0℃, his heart rate was 116 beats/min, and his blood pressure was 188/89 mmHg. His respiratory rate was 26 breaths/min. There were no signs of arthritis, skin rashes, or lymphadenopathy. He did not have any abdominal discomfort or diarrhea. Physical examination was unremarkable except for mild crackles over both lower lobes.
Initial laboratory findings showed a hemoglobin level of 14.4 g/dl, a white blood cell count of 15,000/µl (neutrophil count 83.7%), and a platelet count of 134,000/mm 3 A chest roentgenogram showed bilateral alveolar infiltrates (Fig. 1a) . Chest CT scans showed consolidation and edema with multifocal ground glass opacities (Fig. 1b) . Echocardiography ocardial edema were observed.
The patient was placed on IV moxifloxacin following cultures.
On the second day after admission, intubation was performed due to aggravated hypoxic respiratory failure. The steroid pulse therapy was administered under the suspicion of vasculitis involving the kidney, pulmonary alveolar epithelium, and myocardium.
On fiberoptic bronchoscopy, bronchoalveolar lavage (BAL) fluid obtained from the lateral basal segment of the right lower lobe showed a progressively bloody appearance ( We slowly tapered the steroid dose to 15 mg of oral prednisolone per day after three weeks. After 4 weeks, the patients was discharged in stable condition and followed up regularly.
DISCUSSION
HUS is classified as either diarrhea-associated/typical HUS or non-diarrhea/atypical HUS. Typical HUS making up 90 percent of all cases, is preceded by gastroenteritis with Shiga-toxin-producing bacteria, ranging from three days to more than two weeks. [6] On the contrary, atypical HUS is associated with a variety of causes including dysregulation of the alternative complement pathway, autoimmune disorders, cancers, drugs (VEGF inhibitors such as bevacizumab), bone marrow transplantation, and infection. [7] The distinction of pathogenesis is blurred because Shiga toxin can also mediate alternative complement pathway activation and acquired complement dysfunction in typical HUS. [8] In this case, no clinical symptoms of typical HUS were present except for the presence of EHEC toxin on PCR. In addition, the excellent response to plasma exchange raises the possibility of atypical HUS. Among the etiologies of atypical HUS, human immunodeficiency virus infection, malignancy, and immune-related diseases were excluded. The C3 and C4 levels were normal, but a complete genetic analysis for factor H, factor I, factor B, membrane cofactor protein (CD46) and ADMAMTS-13
could not be performed due to lack of utility. It is unclear wheth- Cardiovascular dysfunction in patients with HUS tends to be underdiagnosed. The mechanisms leading to heart failure are due to volume overload after renal failure or myocardial microinfarctions caused by thrombi in the cardiac circulation. [11] Aggressive treatment including plasma exchange should be initiated immediately due to poor prognosis.
It is remarkable that renal insufficiency, alveolar hemorrhage, and myocarditis could be preceding manifestations prior to the development of typical features such as hemolytic anemia or thrombocytopenia. It accords with the previous report that alveolar hemorrhage and alveolar wall necrosis can occur even in the absence of fibrin thrombus deposition. [12] In atypical HUS, plasmapheresis with infusions of fresh frozen plasma is the first treatment option. [13] Fortunately, our patient showed good response to fifth session of plasma exchange.
The complement blocker, eculizumab (humanized monoclonal anti-C5 immunoglobulin G) should be considered for HUS patients who are resistant to plasma exchange.
In summary, this case highlights uncommon multivisceral complication of atypical HUS. Pulmonary hemorrhage associated HUS should be considered as an uncommon cause. 
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